Citius Pharmaceuticals In... (CTXR)
NASDAQ: CTXR
· Real-Time Price · USD
1.31
0.00 (0.00%)
At close: Aug 15, 2025, 10:10 AM
0.00% (1D)
| Bid | 1.31 |
| Market Cap | 14.64M |
| Revenue (ttm) | 155.93K |
| Net Income (ttm) | -42.64M |
| EPS (ttm) | -4.87 |
| PE Ratio (ttm) | -0.27 |
| Forward PE | 1.86 |
| Analyst | Buy |
| Ask | 1.33 |
| Volume | 25,248 |
| Avg. Volume (20D) | 2,645,898 |
| Open | 1.33 |
| Previous Close | 1.31 |
| Day's Range | 1.30 - 1.33 |
| 52-Week Range | 0.65 - 17.00 |
| Beta | 1.19 |
About CTXR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CTXR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CTXR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Citius Pharmaceuticals Inc. is scheduled to release its earnings on
Dec 26, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 weeks ago
-8.59%
Citius Pharmaceuticals shares are trading lower af...
Unlock content with
Pro Subscription
2 months ago
-22.63%
Citius Pharmaceuticals shares are trading lower after the company announced a $15.8 million registered direct offering. Also, D. Boral Capital lowered its price target on the stock from $9 to $6.
